Cost-Effectiveness Analysis of Treatment Strategies for Stage I and II Endometrial Cancer

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 2, 2007, Pages 131-139

  Kwon, Janice S ^a   Carey, Mark S ^a   Goldie, Sue J ^b   Kim, Jane J ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adjuvant radiotherapy; Cost effectiveness analysis; Endometrial cancer; Surgery; Utility

Indexed keywords

ADJUVANT RADIOTHERAPY; ARTICLE; BRACHYTHERAPY; CANADA; CANCER GRADING; CANCER STAGING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION ANALYTIC MODEL; EARLY CANCER; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE COST; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MYOMETRIUM; NONBIOLOGICAL MODEL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; POPULATION RESEARCH; PREOPERATIVE EVALUATION; QUALITY ADJUSTED LIFE YEAR; SALPINGOOOPHORECTOMY; TUMOR INVASION; DECISION SUPPORT SYSTEM; ECONOMICS; ENDOMETRIUM TUMOR; PATHOLOGY;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING;

EID: 34547588294     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32387-8     Document Type: Article

References (46)

1. Canadian Cancer Society/National Cancer Institute of Canada. Estimated age-standardized incidence rates for major cancer sites by sex and province 2005, Canada.
2. Kwon J.S., Bryson P., Liu G., Peterson K., Stewart M., Davis R.B., et al. A comparison of endometrial cancer outcomes in Ontario. J Obstet Gynaecol Can 2004, 26(9):793-798. September.
3. Creutzberg C.L., van Putten W.L., Warlam-Rodenhuis C.C., van den Bergh A.C., De Winter K.A., Koper P.C., et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004, 22(7):1234-1241. April 1.
4. Boronow R.C., Morrow C.P., Creasman W.T., Disaia P.J., Silverberg S.G., Miller A., et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984, 63(6):825-832. June.
5. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991, 40(1):55-65. January.
6. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., Warlam-Rodenhuis C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000, 355(9213):1404-1411. April.
7. Alektiar K.M., Venkatraman E., bu-Rustum N., Barakat R.R. Is endometrial carcinoma intrinsically more aggressive in elderly patients?. Cancer 2003, 98(11):2368-2377. December 1.
8. Keys H.M., Roberts J.A., Brunetto V.L., Zaino R.J., Spirtos N.M., Bloss J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004, 92(3):744-751. March.
9. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis R.J., Samuels J.R., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998, 70(2):165-171. August.
10. Greven K.M., Corn B.W., Case D., Purser P., Lanciano R.M. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?. Int J Radiat Oncol Biol Phys 1997, 39(2):413-418. September 1.
11. Boronow R.C. Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge-a personal perspective. Gynecol Oncol 1997, 66(2):179-189. August.
12. Maneschi M., Maneschi F., Geraci P., Licata M.D., Serruto A., Attanasio P., et al. Surgical pathological staging of endometrial carcinoma and results of treatment. Eur J Gynaecol Oncol 1992, 13(1):30-35. Suppl.
13. Laupacis A., Feeny D., Detsky A.S., Tugwell P.X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992, 146(4):473-481. February 15.
14. Gold M.R., Siegel J.E., Russel L.B., Weinstein M.C. Cost-effectiveness in health and medicine 1996, Oxford University Press, New York.
15. Franchi M., Ghezzi F., Riva C., Miglierina M., Buttarelli M., Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol 2001, 78(4):232-237. December.
16. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis R.J., Samuels J.R., et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998, 70(2):165-171. August.
17. Kwon J.S., Carey M.S., Cook E.F., Qiu F., Paszat L. Patterns of practice and outcomes in Stage I and II intermediate and high risk endometrial cancer: A population-based study. Int J Gynecol Cancer 2006, In press.
18. Ness R.M., Holmes A.M., Klein R., Dittus R. Utility valuations for outcome states of colorectal cancer. Am J Gastroenterol 1999, 94(6):1650-1657. June.
19. Bennett C.L., Chapman G., Elstein A.S., Knight S.J., Nadler R.B., Sharifi R., et al. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol 1997, 32(3):86-88. Suppl.
20. Stewart S.T., Lenert L., Bhatnagar V., Kaplan R.M. Utilities for prostate cancer health states in men aged 60 and older. Med Care 2005, 43(4):347-355. April.
21. Cowen M.E., Miles B.J., Cahill D.F., Giesler R.B., Beck J.R., Kattan M.W. The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients. Med Decis Making 1998, 18(4):376-380. October.
22. Kim J.J., Wright T.C., Goldie S.J. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002, 287(18):2382-2390. May 8.
23. Fryback D.G., Dasbach E.J., Klein R., Klein B.E., Dorn N., Peterson K., et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993, 13(2):89-102. April.
24. Gold M.R., Franks P., McCoy K.I., Fryback D.G. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998, 36(6):778-792. June.
25. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002, 360(9340):1131-1135. October 12.
26. Statistics Canada. Complete life table, Canada, 1995-1997. Females 2006, Available at, Accessed October 30. http://www.statcan.ca/english/freepub/84-537-XIE/1997001/tables.htm.
27. Macones G.A., Goldie S.J., Peipert J.F. Cost-effectiveness analysis: an introductory guide for clinicians. Obstet Gynecol Surv 1999, 54(10):663-672. October.
28. Bye A., Trope C., Loge J.H., Hjermstad M., Kaasa S. Health-related quality of life and occurrence of intestinal side effects after pelvic radiotherapy-evaluation of long-term effects of diagnosis and treatment. Acta Oncol 2000, 39(2):173-180.
29. Miller B.E., Pittman B., Case D., McQuellon R.P. Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinic. Gynecol Oncol 2002, 87(2):178-184. November.
30. Chan J.L., Kabeto M.U., Oldread A.E., Paisley K.L., Bennett J.E., Sandler H.M., et al. The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma. Int J Radiat Oncol Biol Phys 2002, 53(4):934-941. July.
31. Saigal C.S., Gornbein J., Nease R., Litwin M.S. Predictors of utilities for health states in early stage prostate cancer. J Urol 2001, 166(3):942-946. September.
32. Larson D.M., Broste S.K., Krawisz B.R. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998, 91(3):355-359. March.
33. Orr J.W., Holimon J.L., Orr P.F. Stage I corpus cancer: is teletherapy necessary?. Am J Obstet Gynecol 1997, 176(4):777-788. April.
34. Creutzberg C.L., van Putten W.L., Koper P.C., Lybeert M.L., Jobsen J.J., vRodenhuis C.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 2001, 51(5):1246-1255. December 1.
35. Ontario Ministry of Health and Long-Term Care. Ontario Case Costing Initiative 2006.
36. Statistics Canada. The aging population and retirement. 4 A.D. Nov 17.
37. 14th International Meeting Of The European Society Of Gynaecological Oncology (ESGO) Istanbul, Turkey, September 25-29 2005. Int J Gynecol Cancer 2005, 15(2):51-184. September.
38. Ashih H., Gustilo-Ashby T., Myers E.R., Andrews J., Clarke-Pearson D.L., Berry D., et al. Cost-effectiveness of treatment of early stage endometrial cancer. Gynecol Oncol 1999, 74(2):208-216. August.
39. Fanning J. Treatment for early endometrial cancer. Cost-effectiveness analysis. J Reprod Med 1999, 44(8):719-723. August.
40. Konski A.A., Bracy P.M., Jurs S.G., Weiss S.J., Zeidner S.R. Cost minimization analysis of various treatment options for surgical stage I endometrial carcinoma. Int J Radiat Oncol Biol Phys 1997, 37(2):367-373. January.
41. Fanning J., Hoffman M.L., Andrews S.J., Harrah A.W., Feldmeier J.J. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Gynecol Oncol 2004, 93(3):632-636. June.
42. Kennedy A.W., Austin J.M., Look K.Y., Munger CB. The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences. Gynecol Oncol 2000, 79(3):379-398. December.
43. Maggino T., Romagnolo C., Landoni F., Sartori E., Zola P., Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 1998, 68(3):274-279. March.
44. Maggino T., Romagnolo C., Zola P., Sartori E., Landoni F., Gadducci A. An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer 1995, 31(12):1993-1997. November.
45. Straughn J.M., Huh W.K., Kelly F.J., Leath C.A., Kleinberg M.J., Hyde J., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2002, 84(2):194-200. February.
46. Victory R., Carey M.S., Stitt L. Predictors of length of stay for inpatients having benign gynaecological surgery. J Obstet Gynaecol Can 2005, 27(1):43-50. January.